<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Increased sensitivity to TNF-α promotes keloid fibroblast hyperproliferation by activating the NF-κB, JNK and p38 MAPK pathways.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Increased sensitivity to TNF-α promotes keloid fibroblast hyperproliferation by activating the NF-κB, JNK and p38 MAPK pathways." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/8005672/e22745939843/etm-21-05-09933-g00.jpg"/> </div> <div class="text-side"> <h1>Increased sensitivity to TNF-α promotes keloid fibroblast hyperproliferation by activating the NF-κB, JNK and p38 MAPK pathways.</h1> <p>Expression of TNF-α, sTNFR1 and sTNFR2 in keloid tissue and normal skin. The content of TNF-α, sTNFR1 and sTNFR2 was detected by ELISA (A) in the culture supernatants of (n=9) of primary fibroblasts isolated from keloid or normal skin of patients, and (B) in peripheral blood samples (n=5) from patients with keloids or healthy participants. (C) mRNA levels of TNF-α, sTNFR1 and sTNFR2 in keloid or normal fibroblasts were detected by quantitative PCR analysis and β-actin served as the reference gene (n=6). (D) Dermis from patients with keloids or healthy participants was embedded in paraffin and used to detect the protein levels of TNF-α, sTNFR1 and sTNFR2 by immunohistochemistry (magnification, x400). (E) Results were quantitated and the mean optical density was plotted as a histogram to compare the protein levels (healthy n=9; keloid n=10). *P&lt;0.05 vs. normal. Data are presented as the mean ± SD. TNF, tumor necrosis factor; sTNFR, soluble TNF receptor.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33791011/" target="_blank">33791011</a></p><p>Type: Benign, Category: Fibrohistiocytic</p>
</div> </div></div></body></html>